RIO DE JANEIRO, BRAZIL - On Monday, May 25th, the World Health Organization (WHO) suspended the use of hydroxychloroquine in research it had been coordinating with scientists from 100 countries.
The temporary suspension was decided until the drug's safety is reassessed, since recent studies have shown that it is not effective against Covid-19 and may even increase the mortality rate.
The WHO says that the remaining trials are continuing within the international initiative called "Solidarity". In addition to the drug now vetoed, researchers are also evaluating the results of three types of antivirals and one drug used to treat . . .